Overview

Observational Study With InnoLet® in Daily Clinical Practice

Status:
Completed
Trial end date:
2005-03-23
Target enrollment:
Participant gender:
Summary
This study is conducted in Asia. The aim of this study is to review the efficacy and safety of insulin treatment with InnoLet® in daily clinical practice.
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc